Frontiers | Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial
Impact of renin–angiotensin–aldosterone system inhibitors on COVID-19 | Hypertension Research
Angiotensin-Converting Enzyme Inhibitor vs. Angiotensin Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
DISCHARGE INITIATION OF ACE INHIBITORS OR ARBS IS ASSOCIATED WITH SIGNIFICANTLY LOWER 30-DAY ALL-CAUSE READMISSION IN HOSPITALIZED OLDER PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION | Journal of the American College
ACE inhibitors - Drug cabinet - Heart Matters magazine - BHF
IJMS | Free Full-Text | Two Opposing Functions of Angiotensin-Converting Enzyme (ACE) That Links Hypertension, Dementia, and Aging
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly | NEJM
Prescribing ACE inhibitors: time to reconsider old habits
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19 - ScienceDirect
A Pair of “ACEs” - E.V. Hersh, M. Wolff, P.A. Moore, K.N. Theken, H. Daniell, 2022
Frontiers | Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer's disease
Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care | Journal of the American College of Cardiology
Treatment of Hypertension in the Elderly
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research
Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 | Hypertension Research
Frontiers | Angiotensin Converting Enzyme Inhibitors Combined with Exercise for Hypertensive Seniors (The ACES Trial): Study Protocol of a Randomized Controlled Trial
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? - ScienceDirect
Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?—Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient mice— | Hypertension Research
Hypertension in adults: the silent killer - bpacnz
Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension
Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? | Journal of the American College of Cardiology
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials - The Lancet
Frontiers | Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer's disease, sarcopenia, cancer, and COVID-19
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition | Hypertension Research
